Koelis
France - Auvergne-Rhône-AlpesBiotechnology
Focus: Koelis is a France-based biotechnology company specializing in advanced prostate biopsy and focal therapy systems, operating at Series B stage with a focused oncology portfolio.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
SERIES B
Open Jobs
1
Should You Work at Koelis?
AI assessmentBest suited for mission-driven early-stage operators comfortable with uncertainty in exchange for equity upside and hands-on impact in precision prostate cancer care.
Why Work Here
- Focused pipeline in high-unmet-need prostate cancer space with 6 active programs spanning biopsy guidance, focal therapy, and ablation technologies
- Early-stage company at Series B allows for meaningful individual impact and equity upside potential in a growing medtech/biotech segment
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
1 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Interstitial Brachytherapy of the Prostate With Iodine 125 Implant With Target Dose Supplementation in the Tumor Volume Guided by the TRINITY® PERINE 3D
Prostate CancerClinical Trials (1)
NCT05322356Prostate Interstitial Brachytherapy With I125 Implant With Target Dose Supplementation in the Tumor Volume Guided by TRINITY® PERINE 3D System
N/AHelp build intelligence for Koelis
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.